---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008080"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T06:16:53.792495+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Anebulo faces Nasdaq delisting risk after change of control; enters lock-up with 22NW

## Summary
- Nasdaq determined that Dec 2024 private placement caused a change of control, violating Listing Rule 5635(b); company received notice Feb 20, 2025.
- Company entered lock-up agreement with 22NW (Aron English) on Feb 24, 2025, restricting voting/sale of 10.1M shares until stockholder approval.
- Nasdaq granted extension until April 10, 2025 to obtain stockholder approval; annual meeting scheduled April 4, 2025.
- Joseph Lawler entities have agreed to vote in favor of removing lock-up restrictions, which would ratify the change of control.
- Failure to obtain stockholder approval by April 10, 2025 may result in delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-25-008080
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315225008080/0001493152-25-008080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315225008080/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008080
- JSON: https://secwatch.observer/filing/0001493152-25-008080.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.